mild side effects of Humira may include injection site reactions, such as: Studies show the most common long-term risks include serious infections, lymphoma, and other types of cancer. One study ...

Humira is currently the world’s biggest-selling ... for its C-met-targeting lung cancer ADC Emrelis.

A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were ...

Looking forward, AbbVie's pipeline is weighted more toward new cancer and immunology drugs. The company should be able to leverage its solid entrenchment with Humira and Imbruvica to launch the ...

Humira is already facing competition from biosimilars ... AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in early ...

Humira treats the same conditions — and then ... negative hit due to a tax charge and milestone expenses. Revenue from cancer ...